文献速递外周动脉疾病

衰弱与非九旬老人下肢血管造影后不良结局无关

Frailty is Not Associated with Worse Outcomes following Lower Extremity Angiograms for Limb Ischemia in Nonagenarians.
PubMed 文献 · Ann Vasc Surg · 2023-04-10

回顾性分析2009至2021年单中心76例≥90岁因急性或慢性肢体威胁性缺血行下肢血管造影患者,30天截肢率6%、死亡率8%,12个月存活者肢体挽救率98%;按MFI-11评分35%为衰弱,衰弱与30天及12个月结局均无显著差异;早期截肢者12个月死亡率显著高于未截肢者(83% vs 19%,P < 0.01)。

要点

  • 九旬老人下肢血管内介入30天截肢率6%、死亡率8%。
  • 30天截肢者12个月死亡率83%,显著高于未截肢者的19%。
  • MFI-11定义的衰弱与30天及12个月结局无显著关联。

核心结论

  • 九旬老人行血管内介入安全,死亡率和截肢率低。
  • 早期截肢患者12个月死亡风险显著更高。
  • 经效度指数评估的衰弱与早期或晚期结局无关。
  • 与即刻截肢相比,应告知九旬患者及其家属微创血管内介入的获益。

研究设计与样本

  • 单中心回顾性研究,纳入2009至2021年≥90岁因急性肢体缺血或慢性肢体威胁性缺血行下肢血管造影的患者76例(男性36%),平均年龄93岁(范围90-102)。
  • 急性肢体缺血13例,慢性肢体威胁性缺血63例。
  • 主要结局为30天和12个月肢体挽救率与死亡率,同时回顾患者人口学特征、30天并发症和12个月靶血管再干预率。
  • 衰弱评分采用11因子改良衰弱指数(MFI-11)计算。

主要发现

  • 30天截肢率和死亡率分别为6%和8%。
  • 30天时有随访数据的72例(94%)中,死亡率8%;30天存活者中94%肢体挽救成功。
  • 12个月时有完整随访数据的58例中,存活者(75%)的肢体挽救率为98%。
  • 30天截肢者12个月死亡率显著高于未截肢者(83% vs 19%;P < 0.01)。
  • 按MFI-11评分,35%的患者被判定为衰弱(≥0.27);衰弱患者30天结局(肢体挽救:94% vs 88%;死亡率8% vs 9%,P = 0.41和0.94)及12个月结局(肢体挽救:82% vs 94%;死亡率:32% vs 22%,P = 0.28和0.39)均无显著差异。

临床怎么用

  • 与即刻截肢相比,应告知九旬患者及其家属微创血管内介入的获益。
  • 早期截肢患者12个月死亡风险显著更高。
  • 衰弱状态未显示与早期或晚期结局相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular interventions are performed routinely with minimal risk in younger populations. The safety and efficacy of endovascular interventions in nonagenarians is under examined. We sought to examine the following (1) mortality and limb salvage rates in the nonagenarian population and (2) whether frailty was associated with outcomes following lower extremity (LE) interventions for both acute limb ischemia (ALI) and chronic limb threatening ischemia (CLTI). METHODS: A retrospective review of patients ≥90 years who underwent a LE angiogram for ALI or CLTI over a 12-year period at a single institution was performed. Primary outcomes were 30-day and 12-month limb salvage and mortality rates. Patient demographics, 30-day complications, and 12-month target vessel reintervention (TVR) were reviewed. Frailty scores were calculated using the 11-factor modified frailty index (MFI-11). RESULTS: From 2009 to 2021, 76 patients (36% male) with a mean age of 93 (range: 90-102) underwent endovascular procedures for ALI (n = 13) and CLTI (n = 63). 30-day amputation and mortality rates were 6% and 8%, respectively. Patient demographics, preoperative functional status, and TVR rates were not different between patients who had early amputation (≤30 days) and those who achieved limb salvage. Seventy-two patients (94%) had follow-up data at 30 days. There was an 8% mortality rate at 30 days. Of those alive at 30 days, 94% of patients had successful limb salvage. Fifty-eight patients had complete follow-up data at 12 months. Of the patients alive at 12-month follow-up (75%), the limb salvage rate was 98%. Patients with amputation at 30 days had a significantly higher mortality rate at 12 months compared to those who did not (83% vs. 19%; P < 0.01). Based on MFI-11 scoring, 35% of the population was considered frail (≥0.27). Frail patients did not have significantly different 30-day outcomes (limb salvage: 94% vs. 88%; mortality 8% vs. 9%, P = 0.41 and 0.94, respectively) or 12-month outcomes (limb salvage: 82% vs. 94%; mortality: 32% vs. 22%, P = 0.28 and 0.39, respectively). CONCLUSIONS: Endovascular procedures can be done safely in nonagenarians with low mortality and amputation rates. Patients with early amputation are at significantly higher risk of death at 12 months. Frailty, as measured by a validated index, was not associated with early or late outcomes. When compared to immediate amputation, nonagenarian patients and their families should be counseled as to the benefit from a minimally invasive endovascular procedure.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. DeRieux J, Obed D, Johnson A, et al. Frailty is Not Associated with Worse Outcomes following Lower Extremity Angiograms for Limb Ischemia in Nonagenarians. Ann Vasc Surg. 2023. PMID: 37044241. doi:10.1016/j.avsg.2023.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。